January 18, 2021

The Niche

Trusted stem cell blog & resources

ISSCR

7 min read

To get at addressing what’s the real deal on the idea of cellular therapies for COVID-19, I did a short email Q&A interview with Dr. Sean Morrison. Sean is Chair of the Public Policy Committee at ISSCR and Director of Children’s Research Institute at UT Southwestern. He was also President of ISSCR in 2015-2016, and during his tenure I interviewed him here on The Niche about the challenges and future of the stem cell/regenerative medicine field. You can read more about the Morrison lab …Read More

2 min read

One of the highlights of Day 1 of #ISSCR2018 for me so far was the talk by Lorenz Studer (Co-Founder of BlueRock) on the use of human embryonic stem cell (HESC)-derived dopamine neurons for Parkinson’s Disease. Note that for this post and if I have time any others on this meeting, they are probably going to be somewhat stream of consciousness notes from the talks and may have some outlined points rather than sentences. I have some questions or notes for myself that I …Read More

6 min read

I recently chatted with Sean Morrison, current President of ISSCR, on his goals for the Society, where the stem cell field stands today, top challenges, and the future. 2020 update: read my new interview with Sean on cell therapies for COVID-19. What are your goals for your tenure as President of ISSCR? SM: ISSCR is the international voice for research in the scientific community. There’s been less effort though amongst policy makers and the general public. I want to expand the reach beyond just the …Read More

25 min read

By Michael Cea Jeanne Loring of the Scripps Research Institute in La Jolla, California kindly sat down with me at the ISSCR annual meeting for a broad discussion of her history, views on the field and developments in the science. I found Jeanne a refreshing character, as I did a number of others I was fortunate to meet in Sweden. Her style I can only best describe as natural. It must be the Southern California air or something but there is a definite quality of relaxed …Read More

4 min read

The day of plenary is the most enjoyable in my view including at ISSCR 2015 on the first day with a Yamanaka talk. You don’t need to make the choice between sessions and the judgement on the viability of shifting sessions versus staying put and listening to the slightly less relevant. ISSCR 2015 plenary was, as to be expected, full of the big names, the affectionately known Rusty (Fred Gage), Jonas Frisen (one of the smartest MD PhDs I have ever met) and of …Read More

2 min read

The annual ISSCR meeting has started in Stockholm. This is always a great annual meeting both for the science and for connecting with people including new friends and colleagues as well as old friends. Another element to the meeting is the insider conversations in the halls, restaurants, and bars that tell a behind the scenes story of the stem cell field. Below are my top 10 things to look for that might be discussed over a beer or coffee this year. Also be sure to check …Read More

2 min read

I wish I was going to be with all you who are attending the ISSCR Annual Meeting in Stockholm coming up in a week or so, but this year the schedule just doesn’t work. I’ll try to be there in spirit. For those of you attending, I do have something fun though and a chance to win some money. I’m inviting attendees of ISSCR to submit entries in two contests: (1) guest blog posts and (2) pictures or videos from the meeting itself or …Read More

8 min read

Note that you can register for ISSCR Stockholm here and the early registration deadline is today, March 11. Even without ISSCR Stockholm is a city worth visiting! There is no Eiffel Tower, Colosseum or Big Ben but Stockholm is one of Europe’s best kept secrets and the most beautiful European city I have visited. This ‘Venice of the North’ has been selected for the 2015 ISSCR conference and after over 5 years of living in Stockholm to do my PhD I wanted to share …Read More

2 min read

What were people saying about STAP cells at the ISSCR 2014 meeting? It was a tale of two meetings when it came to STAP at ISSCR. Officially, bigwigs at the podiums only briefly mentioned it and they seemed to collectively argue that STAP was something unfortunate, but that the bigger danger was the overreaction to it. Thus, remarkably their key concern seemed to be their perception of an overreaction to STAP rather than STAP itself. Outside the lecture halls in the other halls (between …Read More

4 min read

I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and the FDA: a match not made in heaven? The ISSCR conference day started off a session entitled “Therapies in the Clinic” and my colleague Leigh Turner kicked things off with a …Read More